VALIDOGEN GmbH logo — UNLOCK PICHIA® - Pichia pastoris protein expression excellen...

VALIDOGEN GmbH

UNLOCK PICHIA® - Pichia pastoris protein expression excellence

Founded 2008 Austria Austria 15 employees Biotechnology, Pharmaceutical

General Information

Company Name VALIDOGEN GmbH
Founded Year 2008
Location Austria Austria +1
Employees 15
Industries Biotechnology, Pharmaceutical
Social

Get notified when VALIDOGEN GmbH moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About VALIDOGEN GmbH

VALIDOGEN, founded in 2008 as VTU Technology GmbH and renamed VALIDOGEN GmbH in October 2018, is a leading contract research and development organization (CRO) specializing in recombinant protein expression using its exclusive UNLOCK PICHIA® protein expression technology. With its UNLOCK PICHIA® platform, VALIDOGEN applies a broad and unique portfolio of technologies for successful and economically viable production of recombinant proteins in the yeast Pichia pastoris (also known as as Komagataella phaffii), serving many industries including biopharma, food & feed, industrial biotechnology, and diagnostics. VALIDOGEN provides advanced Pichia strain generation as well as fermentation and protein purification process development for the manufacture of biopharmaceuticals, enzymes, and other recombinant proteins. Based on our strong Pichia expertise, customers from different industries have successfully scaled up commercial production processes with highly effective Pichia strains for the production of recombinant proteins for pharma and non-pharma applications. Headquartered in Raaba-Grambach, near Graz, Austria, VALIDOGEN is a private company and subsidiary of KonValue Holding GmbH. WORKING WITH VALIDOGEN 15+ YEARS EXPERIENCE Pichia strain generation & optimization, plus process development for enhanced protein production UNLOCK PICHIA® TOOLBOX Broad and versatile protein expression technology platform for Pichia pastoris CUSTOMER-ORIENTED SERVICES Customized project plans in small, modular packages suitable for every industry _____________________________________________________________________________ For more information on VALIDOGEN and how we UNLOCK PICHIA® for maximization of protein production visit www.validogen.com

No funding data available for VALIDOGEN GmbH yet.

Get notified when VALIDOGEN GmbH raises funding

VALIDOGEN GmbH Alternatives & Competitors

VALIDOGEN GmbH vs

Headquartered in San Diego, California, Pfīnex Inc. is a prominent biotechnology company specializi...

Post Ipo Equity
51-200 employees
Biotechnology, Health Care
VALIDOGEN GmbH vs
U-Protein Express BV
U-Protein Express BV The Netherlands

U-Protein Express BV was acquired by ImmunoPrecise Antibodies Ltd.. Visit www.ImmunoPrecise.com for...

8 employees
Biotechnology
VALIDOGEN GmbH vs

Streamlining protein therapeutics development

14 employees

FAQ About VALIDOGEN GmbH

UNLOCK PICHIA® - Pichia pastoris protein expression excellence
VALIDOGEN GmbH was founded in 2008.
VALIDOGEN GmbH is headquartered in Austria.
VALIDOGEN GmbH operates in the following industries: Biotechnology, Pharmaceutical.
VALIDOGEN GmbH has approximately 15 employees.
Top alternatives and competitors to VALIDOGEN GmbH include Pfenex, U-Protein Express BV, Pelican Expression Technology®, enGenes Biotech GmbH, Wuhan Healthgen Biotechnology Corp.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
VALIDOGEN GmbH and Pfenex are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors VALIDOGEN GmbH and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy